NeuroAIDS in Africa.

Area of Science:

• Neuroscience
• Infectious Diseases
• Public Health

Background:

• HIV/AIDS remains a significant public health concern in sub-Saharan Africa.
• HIV-associated neurocognitive disorders (HANDs) represent a growing challenge in affected populations.
• Understanding the epidemiology and impact of HANDs is crucial for effective management.

Purpose of the Study:

• To convene experts and stakeholders to discuss the current state of NeuroAIDS in Africa.
• To identify key challenges and opportunities in NeuroAIDS research and clinical care.
• To foster collaboration and capacity building for addressing HIV's neurological impact.

Main Methods:

• A meeting titled "NeuroAIDS in Africa" was organized, affiliated with the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention.
• Presentations covered HIV epidemiology, molecular epidemiology, HANDs, and HAND treatment.
• Discussions included country-specific research and clinical care updates from various African nations.

Main Results:

• The meeting provided an overview of HANDs epidemiology and treatment in sub-Saharan Africa.
• Country-specific data on HAND research and clinical care were presented from Botswana, Cameroon, Ethiopia, The Gambia, Kenya, Malawi, Nigeria, Senegal, South Africa, Uganda, and Zambia.
• Key topics included CNS involvement, subtype-associated risks, pediatric neurodevelopment, opportunistic infections, and treatment implementation.

Conclusions:

• There is a critical need for enhanced NeuroAIDS research and capacity building in Africa.
• Standardized assessment tools and tailored treatment strategies are essential for managing HANDs.
• Addressing NeuroAIDS requires a multidisciplinary approach and regional collaboration.